• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林钠:稳态血浆水平与患者年龄

Warfarin sodium: steady-state plasma levels and patient age.

作者信息

Hotraphinyo K, Triggs E J, Maybloom B, Maclaine-Cross A

出版信息

Clin Exp Pharmacol Physiol. 1978 Mar-Apr;5(2):143-9. doi: 10.1111/j.1440-1681.1978.tb00664.x.

DOI:10.1111/j.1440-1681.1978.tb00664.x
PMID:648034
Abstract
  1. Steady-state plasma levels of warfarin were measured in thirty-nine ambulatory patients attending a haematology clinic. 2. Plasma concentrations, plasma clearance, and prothrombin ratio showed no significant differences when patients below 65 years of age were compared with those above 65 years. The mean daily maintenance dose of warfarin required was marginally greater for the younger patients but the difference was not statistically significant (P = 0.10). 3. A significant relationship was found between the daily maintenance dose of warfarin required by all patients and their mean steady-state plasma level (r = 0.5667, P less than 0.001). 4. For one elderly hospitalized patient it was apparent that there was a marked depression of the vitamin K-dependent clotting factor synthesis by warfarin which was associated with a hypoprothrombinaemic response.
摘要
  1. 在一家血液科门诊就诊的39名门诊患者中测量了华法林的稳态血浆水平。2. 将65岁以下患者与65岁以上患者进行比较时,血浆浓度、血浆清除率和凝血酶原比值无显著差异。年轻患者所需的华法林平均每日维持剂量略高,但差异无统计学意义(P = 0.10)。3. 发现所有患者所需的华法林每日维持剂量与其平均稳态血浆水平之间存在显著相关性(r = 0.5667,P < 0.001)。4. 对于一名老年住院患者,很明显华法林使维生素K依赖的凝血因子合成明显受到抑制,这与低凝血酶原血症反应有关。

相似文献

1
Warfarin sodium: steady-state plasma levels and patient age.华法林钠:稳态血浆水平与患者年龄
Clin Exp Pharmacol Physiol. 1978 Mar-Apr;5(2):143-9. doi: 10.1111/j.1440-1681.1978.tb00664.x.
2
Age as a determinant of sensitivity to warfarin.年龄作为华法林敏感性的一个决定因素。
Br J Clin Pharmacol. 1977 Jun;4(3):315-20. doi: 10.1111/j.1365-2125.1977.tb00719.x.
3
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.维生素K1 2,3-环氧化物还原酶的抑制与华法林导致的凝血因子活性降低之间的关系。
Br J Clin Pharmacol. 1988 Jan;25(1):1-7. doi: 10.1111/j.1365-2125.1988.tb03274.x.
4
Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.华法林对大鼠维生素K依赖凝血因子动力学的影响。
J Pharmacol Exp Ther. 1977 May;201(2):507-17.
5
Pharmacokinetics and pharmacodynamics of warfarin at steady state.华法林稳态时的药代动力学和药效学
Br J Clin Pharmacol. 1979 Sep;8(3):243-7. doi: 10.1111/j.1365-2125.1979.tb01009.x.
6
Smoking and warfarin disposition.吸烟与华法林的代谢
Clin Pharmacol Ther. 1979 Mar;25(3):309-15. doi: 10.1002/cpt1979253309.
7
Warfarin and warfarin-alcohol levels in anticoagulated patients.
Aust N Z J Med. 1979 Oct;9(5):534-7. doi: 10.1111/j.1445-5994.1979.tb03390.x.
8
Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.华法林对映体的药代动力学:寻找个体内相关性。
Clin Pharmacol Ther. 1978 Feb;23(2):212-7. doi: 10.1002/cpt1978232212.
9
The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.西咪替丁对人体华法林稳态药代动力学和药效学的影响。
Eur J Clin Pharmacol. 1999 Jul;55(5):399-404. doi: 10.1007/s002280050647.
10
Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.抗凝患者中维生素K1代谢与药效学反应的关系。
Br J Clin Pharmacol. 1985 Dec;20(6):643-8. doi: 10.1111/j.1365-2125.1985.tb05123.x.

引用本文的文献

1
Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin.成人年龄对(R)-和(S)-华法林总清除率、游离清除率和蛋白结合率的影响。
Br J Clin Pharmacol. 2012 Nov;74(5):797-805. doi: 10.1111/j.1365-2125.2012.04259.x.
2
Free drug metabolic clearance in elderly people.老年人的游离药物代谢清除率。
Clin Pharmacokinet. 2008;47(5):297-321. doi: 10.2165/00003088-200847050-00002.
3
Drugs in the elderly.老年人用药
Bull N Y Acad Med. 1980 Oct;56(8):703-14.
4
Population pharmacokinetics of racemic warfarin in adult patients.
J Pharmacokinet Biopharm. 1985 Jun;13(3):213-27. doi: 10.1007/BF01065653.
5
Investigation of patients with abnormal response to warfarin.对华法林反应异常患者的调查。
Br J Clin Pharmacol. 1986 Jul;22(1):37-41. doi: 10.1111/j.1365-2125.1986.tb02877.x.
6
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.华法林的临床药代动力学与药效学。理解剂量效应关系。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005.
7
Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.老年患者单次静脉注射和口服维拉帕米后的药物处置及心血管效应
Cardiovasc Drugs Ther. 1989 Jun;3(3):417-25. doi: 10.1007/BF01858113.
8
Hepatic drug metabolism and aging.肝脏药物代谢与衰老
Clin Pharmacokinet. 1990 Nov;19(5):359-89. doi: 10.2165/00003088-199019050-00002.